W
ABBV icon

WealthCollab’s AbbVie ABBV Stock Holding History

WealthCollab’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$94.1K Sell
374
-26
-7% -$5.59K 0.03% 163
2026
Q1 		$87K Hold
400
– – 0.04% 144
2025
Q4 		$91.4K Sell
400
-1
-0.2% -$228 0.04% 138
2025
Q3 		$92.8K Buy
401
+42
+12% +$8.55K 0.04% 123
2025
Q2 		$66.6K Buy
359
+6
+2% +$1.11K 0.04% 150
2025
Q1 		$74K Buy
353
+5
+1% +$972 0.05% 124
2024
Q4 		$61.8K Buy
348
+128
+58% +$23.5K 0.04% 139
2024
Q3 		$43.4K Sell
220
-26
-11% -$4.85K 0.03% 177
2024
Q2 		$42.2K Sell
246
-11
-4% -$1.82K 0.03% 175
2024
Q1 		$46.8K Buy
257
+11
+4% +$1.9K 0.03% 162
2023
Q4 		$38.1K Buy
+246
New +$35.9K 0.03% 160

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

WealthCollab's ABBV Position: Q2 2026 in Review

WealthCollab reduced its AbbVie (ABBV) stake by 6.5% in Q2 2026, selling an estimated $5.59K and leaving 374 shares worth $94.1K. The position accounts for 0.03% of the portfolio, ranked #163.

WealthCollab first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • WealthCollab held 374 shares of AbbVie worth $94.1K as of Q2 2026.
  • WealthCollab sold 26 AbbVie shares in Q2 2026, an estimated $5.59K.
  • AbbVie made up 0.03% of WealthCollab's portfolio in Q2 2026, its #163 holding.
  • WealthCollab first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • 4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on WealthCollab's 13F filing for Q2 2026, filed 10 Aug 2026.